Daily non-political popular news in brief.
No benefit for liver cancer patients from long-acting octreotide
01-02-2007 · EurekAlert!Long-acting octreotide does not improve outcomes for patients with liver cancer compared to a placebo, according to the results of a new double blind study published in the January 2007 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).
Read more »
Keywords: benefit, liver, cancer, patients, long-acting, octreotide, patient, long, acting
« Previous | Next »
Similar news on "No benefit for liver cancer patients from long-acting octreotide":
- Research shows survival benefit for leukemia patients treated with arsenic trioxide
06-04-2007 · EurekAlert!
Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
Similar news · Read more »
- Rapid-acting insulin analogues in diabetes mellitus type 1 -- Superiority not proven
07-17-2007 · EurekAlert!
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1. The evidential value and design of studies available so far are inadequate and do not allow conclusions regarding most patient-relevant therapy goals, such as the reduction in long-term complications or overall mortality. Due to the lack of data, the benefit of rapid-acting insulin analogues in children and adolescents is unclear.
Similar news · Read more »
- Study calculates patient time costs associated with cancer care
01-02-2007 · EurekAlert!
In 2005, the overall cost of patients' time spent on cancer care was $2.3 billion in the first year after diagnosis, according to a new study in the Jan. 3 issue of the Journal of the National Cancer Institute. The time costs for the 11 cancers studied and for different phases of cancer care varied widely, they write.
Similar news · Read more »
- Interleukin-8, key marker for colorectal cancer treatment
10-09-2007 · EurekAlert!
Colorectal cancer constitutes one of the leading causes of cancer-related deaths worldwide. A German research group has shown that the expression of Interleukin-8, a multifunctional cytokine, correlates not only with CRC onset, but also with tumor progression and the development of colorectal liver metastases. The expression level of IL-8 might thus be a useful tool to evaluate the prognosis of patients with CRC with a high likelihood of impact on future treatment strategies.
Similar news · Read more »
- Manic phase of bipolar disorder benefits from breast cancer medication
09-12-2007 · EurekAlert!
The manic phase of bipolar disorder favors destructive behaviors. Stemming it quickly is important. Tamoxifen's effects were dramatic -- 63 percent of patients responded vs. 13 percent on placebo -- and it kicked in faster than many current medications. Tamoxifen skips some of current drugs' biochemical steps and acts directly on the enzyme protein-kinase C, giving scientists a more direct target at which to aim new medications in their search for faster-acting treatments.
Similar news · Read more »
- Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
10-23-2006 · EurekAlert!
While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
Similar news · Read more »
- Cancer patients may benefit from reporting symptoms online in real time
11-29-2007 · EurekAlert!
A new study by researchers at Memorial Sloan-Kettering Cancer Center finds that even the sickest cancer patients are willing and able to "self-report" symptoms using the Internet, thus supplying key data in real time to their health-care providers.
Similar news · Read more »
- Ablation procedure proves safe, effective and fast
06-28-2007 · EurekAlert!
Multiple-electrode radiofrequency ablation is a safe and effective way of treating patients with liver cancer that can be completed in less time than current ablation techniques, according to a recent study conducted by researchers at the University of Wisconsin in Madison.
Similar news · Read more »
- Hospitalized heart failure patients may benefit from oral tolvaptan
03-25-2007 · EurekAlert!
A diagnosis of worsening acute decompensated heart failure (ADHF) is characterized by the development of dyspnea (shortness of breath) associated with the rapid accumulation of fluid in the lungs. Patients who are hospitalized with ADFA need rapid and sustained fluid retention without risking renal dysfunction. Tolvaptan has been shown to achieve rapid and sustained results in this patient population, according to a study presented today at the American College of Cardiology’s 56th Annual Scientific Session.
Similar news · Read more »
- Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
10-12-2006 · ScienceDaily
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
